Acasti's krill oil-derived drug fails late-stage study, shares tumble

Acasti Pharma Inc said on Monday its krill oil-derived drug had failed to beat placebo by a large margin in reducing a type of fat found in blood that increases the risk of heart diseases, sending its shares spiraling down nearly 67%.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news